Physician profile
Saurabh Ranjan
NPI 1598086506
$12,373.84
in general payments reported to CMS, 2019-2025
14 companies · $864 in 2025
The $864 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2021: $374 · 2022: $2,420 · 2023: $6,100 · 2024: $2,307 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,634 · Travel and Lodging: $3,637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,634.03 |
| Travel and Lodging | $3,637.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,345.67 | 2021-2024 | Ekosonic, Watchman Flx, Synergy |
| Abbott Laboratories | $2,685.78 | 2019-2025 | Accent, Assurity, Mitraclip |
| Medtronic, INC. | $2,202.17 | 2022-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Abiomed | $1,048.85 | 2022-2025 | Impella |
| Inari Medical, INC. | $927.77 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $883.75 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $347.89 | 2022-2024 | Sapien 3 Ultra Resilia |
| Stryker Corporation | $263.55 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $223.95 | 2023-2025 | Camzyos |
| Cardiovascular Systems INC. | $156.08 | 2022 | |
| W. L. Gore & Associates, INC. | $135.10 | 2023 | Gore Viabahn Endoprosthesis With Heparin |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.56 | 2024 | Jardiance |
| Terumo Medical Corporation | $37.87 | 2024 | Metacross Otw, Glidewire |
| Penumbra, INC. | $24.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saurabh Ranjan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.